European Medicines Agency Archives

The European Medicines Agency has backed Novo Nordisk’s Wegovy to expand the weight-loss drug’s application to lower heart risks and strokes in non-diabetic adults with obesity, according to a statement from the EU regulator.

Wegovy gets EU regulator backing on lowering heart risks in obese people

The European Medicines Agency has backed Novo Nordisk’s Wegovy to expand the weight-loss drug’s application to lower heart risks and strokes in non-diabetic.

by HealthQuill
July 26, 2024
0 Comments

Bayer AG, a German multinational pharmaceutical and biotechnology company, has bought the marketing rights in Europe for a heart drug for $310 million to expand its cardiology portfolio.

Drugs Health Pharma

Bayer acquires marketing rights for heart drug in Europe for $310 million

HQ Team March 4, 2024: Bayer AG, a German multinational pharmaceutical and biotechnology company, has bought the marketing rights in Europe for a.

by HealthQuill
March 4, 2024
0 Comments

Pfizer Inc., a US pharmaceutical and biotechnology corporation, announced its single dose of respiratory syncytial virus (RSV) vaccine would maintain protection from the disease through to a second season.

Drugs Health Pharma

Pfizer says RSV vaccine can ensure protection into second season

HQ Team March 1, 2024: Pfizer Inc., a US pharmaceutical and biotechnology corporation, announced its single dose of respiratory syncytial virus (RSV) vaccine.

by HealthQuill
March 1, 2024
0 Comments

The FDA cleared BioMarin Pharmaceuticals’s Voxzogo injection for treating achondroplasia, a common form of short-limbed dwarfism in children.

Drugs Health Pharma

BioMarin’s achondroplasia drug gets nod for children of all ages

HQ Team October 21, 2023: The FDA cleared BioMarin Pharmaceuticals’s Voxzogo injection for treating achondroplasia, a common form of short-limbed dwarfism in children.